Big Pharma Makes a Deal: Cheaper Drugs for Medicare

Two major drug companies, Lilly and Novo Nordisk, are close to striking a deal with the White House. They want to offer their weight loss drugs at a lower price. This is big news because it could mean more people can afford these medicines. The plan is to sell the lowest dose of their obesity drugs for $149 a month. This is a big drop from what they usually charge. In return, the government's Medicare program would cover these drugs. Medicare is for people over 65. This deal could help a lot of older Americans who struggle with weight issues. But why is this happening now? Well, the U. S. has been pushing for lower drug prices. This deal could be a win-win. The companies get more customers, and people get cheaper drugs. But will this really make a difference? Only time will tell. Both companies have not said much about this yet. They did not respond to requests for comments. So, we will have to wait for official news. This deal could be announced soon, maybe even this week.